Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Price Negotiation Bill Moves To Full Senate, With Grassley Vowing To Block It

Executive Summary

The Senate is expected to take up Medicare direct price negotiation during the week of April 16, after the Senate Finance Committee cleared a measure developed by Chairman Max Baucus, D-Mont

You may also be interested in...



Senate does not negotiate with Baucus

Medicare direct drug price negotiation bill stalls in the Senate April 18, as Sen. Max Baucus, D-Mont., fails to win enough votes for "cloture," which would bring the Senate to a vote. As passed by the Finance Committee, Baucus' S 3 would permit HHS to negotiate Part D prices with drug manufacturers and add provisions in other areas such as comparative effectiveness research and data sharing with congressional agencies (1"The Pink Sheet" April 16, 2007, p. 4)...

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel